URMC Research Network

Find People
Keyword
Last Name
 
More Search Options

Michael Keefer

Concepts (246)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of pubs Most recent pub Pubs by all authors Concept score Why?
AIDS Vaccines
44
1992
68
5.820
Why?
HIV-1
38
1992
536
3.570
Why?
HIV Infections
25
1993
579
2.110
Why?
HIV Envelope Protein gp120
22
1993
46
1.940
Why?
HIV Antibodies
24
1992
47
1.640
Why?
Genetic Vectors
9
1999
339
1.190
Why?
Vaccinia virus
9
1992
53
1.120
Why?
Vaccines, Synthetic
21
1991
90
1.100
Why?
Gene Products, env
9
1991
14
1.070
Why?
T-Lymphocytes, Cytotoxic
12
1996
128
0.840
Why?
Fowlpox virus
1
2011
1
0.780
Why?
Drug Carriers
1
2011
21
0.760
Why?
Double-Blind Method
27
1989
992
0.740
Why?
Protein Precursors
8
1991
84
0.720
Why?
Canarypox virus
4
2003
4
0.670
Why?
Immunization, Secondary
12
1992
71
0.650
Why?
CD8-Positive T-Lymphocytes
10
1997
224
0.640
Why?
Adult
44
1989
11351
0.610
Why?
Adjuvants, Immunologic
8
1993
117
0.590
Why?
Adolescent
25
1989
4766
0.560
Why?
Vaccination
8
1992
232
0.540
Why?
Immunization
6
1996
175
0.500
Why?
Middle Aged
35
1989
9837
0.450
Why?
Female
38
1991
19838
0.440
Why?
CD4-Positive T-Lymphocytes
9
1992
303
0.420
Why?
Pericarditis, Constrictive
1
2002
4
0.420
Why?
Immunocompetence
1
2002
30
0.410
Why?
Candida
1
2002
23
0.400
Why?
Peptide Fragments
9
1993
282
0.400
Why?
Male
35
1991
19675
0.400
Why?
Candidiasis
1
2002
41
0.400
Why?
Humans
55
1986
36274
0.400
Why?
Neutralization Tests
15
1993
129
0.400
Why?
Avipoxvirus
4
1998
4
0.400
Why?
Young Adult
9
2008
1059
0.400
Why?
Antibodies, Neutralizing
2
2010
32
0.380
Why?
HIV Seronegativity
8
1994
21
0.360
Why?
HIV Envelope Protein gp160
10
1991
15
0.350
Why?
Interferon-gamma
7
1993
348
0.340
Why?
Recombinant Proteins
11
1993
723
0.330
Why?
Immunity, Cellular
7
1991
132
0.300
Why?
Adenoviridae
4
2007
128
0.290
Why?
Squalene
1
1996
3
0.280
Why?
Polysorbates
1
1996
9
0.280
Why?
Vaccines, Subunit
4
2003
11
0.280
Why?
Herpesvirus 1, Human
2
2006
65
0.280
Why?
T-Lymphocytes
6
1993
550
0.270
Why?
Leukocytes, Mononuclear
3
1991
110
0.270
Why?
Epitopes
4
1986
202
0.260
Why?
Amino Acid Sequence
9
1993
1195
0.260
Why?
Viral Vaccines
3
1991
109
0.260
Why?
Dose-Response Relationship, Immunologic
6
1994
60
0.250
Why?
Human Immunodeficiency Virus Proteins
2
2010
2
0.250
Why?
Vaccines, DNA
2
2009
22
0.240
Why?
Time Factors
8
1989
3182
0.240
Why?
Lymphocyte Activation
10
1992
410
0.240
Why?
Enzyme-Linked Immunosorbent Assay
9
1993
462
0.240
Why?
Antibody Specificity
3
1986
106
0.230
Why?
Genes, gag
2
2006
7
0.220
Why?
Antibodies, Anti-Idiotypic
1
2012
51
0.210
Why?
DNA, Viral
3
1997
292
0.210
Why?
Autoantibodies
1
2012
98
0.200
Why?
Spectinomycin
1
1991
6
0.200
Why?
Molecular Sequence Data
8
1993
1988
0.200
Why?
Urethritis
1
1991
11
0.200
Why?
Antigens, Viral
3
2004
149
0.200
Why?
Chlamydia Infections
1
1991
21
0.200
Why?
Placebos
5
1989
178
0.190
Why?
Gene Products, gag
2
2006
17
0.190
Why?
Mannitol
1
2010
32
0.190
Why?
Oleic Acids
1
2010
16
0.190
Why?
Safety
7
1993
101
0.190
Why?
Anti-Infective Agents
1
1991
75
0.180
Why?
Immune Evasion
1
2010
4
0.180
Why?
Antibodies, Viral
6
1992
472
0.180
Why?
Follow-Up Studies
4
1994
1855
0.180
Why?
Abscess
1
2010
51
0.180
Why?
Adenoviridae Infections
1
2010
10
0.180
Why?
Simian immunodeficiency virus
1
2010
28
0.180
Why?
Models, Immunological
1
2010
61
0.170
Why?
CD4 Lymphocyte Count
4
1997
148
0.170
Why?
HIV-2
1
2009
4
0.170
Why?
Antifungal Agents
2
1997
62
0.170
Why?
Epitopes, T-Lymphocyte
1
2009
31
0.170
Why?
Acquired Immunodeficiency Syndrome
3
1992
193
0.170
Why?
Granulocyte-Macrophage Colony-Stimulating Factor
1
2008
81
0.160
Why?
Peptides
1
2010
285
0.160
Why?
National Institutes of Health (U.S.)
3
1994
63
0.160
Why?
Risk-Taking
3
1998
79
0.150
Why?
Cytokines
4
1998
565
0.140
Why?
Treatment Outcome
4
1997
2615
0.140
Why?
Gene Expression Regulation, Viral
1
2006
37
0.140
Why?
Viral Load
3
1997
135
0.140
Why?
Immunization Schedule
6
1996
53
0.130
Why?
Staining and Labeling
1
2005
162
0.120
Why?
Rabies Vaccines
1
2004
6
0.120
Why?
Viral Proteins
1
2005
214
0.120
Why?
Viral Envelope Proteins
1
2004
89
0.110
Why?
Promoter Regions, Genetic
1
2006
553
0.110
Why?
Clinical Trials, Phase II as Topic
2
1998
13
0.110
Why?
Hispanic Americans
1
2004
93
0.110
Why?
Data Interpretation, Statistical
1
2004
157
0.110
Why?
African Continental Ancestry Group
1
2004
125
0.110
Why?
Sex Characteristics
1
2004
138
0.110
Why?
Glycoproteins
1
2004
201
0.110
Why?
Pregnancy
3
1994
1966
0.110
Why?
Pericardiectomy
1
2002
2
0.100
Why?
HIV Antigens
2
1998
11
0.100
Why?
env Gene Products, Human Immunodeficiency Virus
2
2011
13
0.100
Why?
Rare Diseases
1
2002
27
0.100
Why?
Antibody-Dependent Cell Cytotoxicity
2
1998
28
0.100
Why?
European Continental Ancestry Group
1
2004
234
0.100
Why?
Saponins
1
2001
6
0.100
Why?
Cells, Cultured
5
1993
2479
0.100
Why?
HIV Seropositivity
2
1994
34
0.090
Why?
T-Lymphocytes, Regulatory
1
2001
49
0.090
Why?
United States
3
1994
2688
0.090
Why?
Combined Modality Therapy
1
2002
486
0.090
Why?
Infectious Disease Transmission, Vertical
1
1999
47
0.090
Why?
Voluntary Workers
1
1998
7
0.080
Why?
AIDS Serodiagnosis
1
1998
9
0.080
Why?
Immunity, Active
2
1994
9
0.080
Why?
Pregnancy Complications, Infectious
1
1999
84
0.080
Why?
Prejudice
1
1998
51
0.080
Why?
Itraconazole
1
1997
5
0.080
Why?
Histoplasmosis
1
1997
9
0.080
Why?
Antibody Formation
3
1994
179
0.080
Why?
Th1 Cells
1
1998
70
0.080
Why?
AIDS-Related Opportunistic Infections
1
1997
63
0.070
Why?
Risk Assessment
1
2002
884
0.070
Why?
Th2 Cells
1
1998
94
0.070
Why?
Patient Participation
1
1997
73
0.070
Why?
Consumer Product Safety
1
1996
4
0.070
Why?
Immunotherapy
1
1997
86
0.070
Why?
Pregnancy Outcome
1
1997
137
0.070
Why?
Blotting, Western
3
1991
645
0.060
Why?
Mice, Inbred BALB C
2
2006
632
0.060
Why?
Flow Cytometry
2
2005
603
0.060
Why?
Influenza Vaccines
1
1998
264
0.060
Why?
Immunoenzyme Techniques
1
1994
220
0.060
Why?
Research
1
1994
178
0.060
Why?
Cytotoxicity, Immunologic
1
1993
115
0.060
Why?
Immunophenotyping
1
2012
114
0.050
Why?
Animals
6
1986
16093
0.050
Why?
pol Gene Products, Human Immunodeficiency Virus
1
2011
2
0.050
Why?
nef Gene Products, Human Immunodeficiency Virus
1
2011
2
0.050
Why?
gag Gene Products, Human Immunodeficiency Virus
1
2011
6
0.050
Why?
Cross Reactions
2
1986
108
0.050
Why?
Cohort Studies
2
1994
969
0.050
Why?
Aluminum Hydroxide
2
2001
13
0.050
Why?
Immune Tolerance
1
2012
144
0.050
Why?
Injections, Intramuscular
1
1991
71
0.050
Why?
Drug Evaluation
1
1991
101
0.050
Why?
Anemia
1
2011
78
0.050
Why?
Freund's Adjuvant
1
2010
6
0.050
Why?
Hypersensitivity, Delayed
2
2000
49
0.050
Why?
Neoplasms
1
1997
739
0.050
Why?
Founder Effect
1
2010
6
0.050
Why?
Vaccines, Combined
2
1998
20
0.050
Why?
Simian Acquired Immunodeficiency Syndrome
1
2010
17
0.050
Why?
Prospective Studies
3
1997
1689
0.050
Why?
Macaca
1
2010
70
0.040
Why?
Amantadine
1
1989
22
0.040
Why?
RNA, Viral
2
1997
275
0.040
Why?
Immunoglobulin G
1
2011
488
0.040
Why?
Models, Theoretical
1
2010
192
0.040
Why?
Cell Division
1
1991
762
0.040
Why?
Sequence Alignment
1
2009
191
0.040
Why?
B-Lymphocytes
1
2012
432
0.040
Why?
Genes, env
1
2007
7
0.040
Why?
Chromium
1
2007
4
0.040
Why?
Acute Disease
1
2009
586
0.040
Why?
Mice
3
1986
6111
0.040
Why?
3T3 Cells
1
2006
76
0.040
Why?
Antibody Affinity
2
1994
13
0.040
Why?
Employment
2
1994
64
0.040
Why?
Factor V
1
1986
19
0.030
Why?
Aged
3
1993
7269
0.030
Why?
DNA Primers
1
2007
403
0.030
Why?
Megakaryocytes
1
1986
67
0.030
Why?
Plasmids
1
2007
363
0.030
Why?
Dendritic Cells
1
2006
121
0.030
Why?
Influenza, Human
1
1989
350
0.030
Why?
Lymphocytes
2
1993
291
0.030
Why?
Mucous Membrane
1
2004
37
0.030
Why?
Salmonella
1
2003
7
0.030
Why?
Clinical Trials, Phase I as Topic
1
2003
10
0.030
Why?
Time
1
2003
46
0.030
Why?
Leukocyte Count
2
1992
161
0.030
Why?
Base Sequence
1
2007
1683
0.030
Why?
Transcription, Genetic
1
2006
812
0.030
Why?
Cell Line
1
2006
1585
0.030
Why?
Immunity, Mucosal
1
2001
25
0.020
Why?
Microspheres
1
2001
56
0.020
Why?
Vaccines, Attenuated
1
2001
86
0.020
Why?
HIV Protease
1
2001
22
0.020
Why?
Antibody-Producing Cells
1
2001
35
0.020
Why?
Clinical Trials as Topic
1
2005
671
0.020
Why?
Randomized Controlled Trials as Topic
1
2003
411
0.020
Why?
CHO Cells
1
2001
182
0.020
Why?
Administration, Oral
1
2001
308
0.020
Why?
Cricetinae
1
2001
366
0.020
Why?
Retroviridae Proteins
1
1999
10
0.020
Why?
Genes, Viral
1
1999
86
0.020
Why?
False Positive Reactions
1
1998
88
0.020
Why?
Dose-Response Relationship, Drug
2
1989
1117
0.020
Why?
Virus Replication
2
1989
291
0.020
Why?
Rabies virus
1
1998
4
0.020
Why?
Antibodies, Blocking
1
1998
10
0.020
Why?
Cytotoxicity Tests, Immunologic
1
1998
31
0.020
Why?
Sequence Analysis
1
1998
26
0.020
Why?
Substance Abuse, Intravenous
1
1998
15
0.020
Why?
Histoplasma
1
1997
2
0.020
Why?
Antigens, CD4
1
1998
37
0.020
Why?
Polysaccharides
1
1997
43
0.020
Why?
Insurance, Health
1
1998
107
0.020
Why?
Culture Media
1
1998
195
0.020
Why?
Antigens, Fungal
1
1997
34
0.020
Why?
Proviruses
1
1997
9
0.020
Why?
Lymphocyte Count
1
1997
53
0.020
Why?
Virus Cultivation
1
1996
30
0.020
Why?
Recurrence
1
1997
691
0.020
Why?
Longitudinal Studies
1
1997
395
0.020
Why?
Incidence
1
1998
685
0.020
Why?
Survival Analysis
1
1997
606
0.020
Why?
Reference Values
1
1996
439
0.020
Why?
Insurance, Life
1
1994
2
0.020
Why?
Phenotype
1
1998
763
0.020
Why?
Polymerase Chain Reaction
1
1997
596
0.020
Why?
Infant, Newborn
1
1999
1844
0.020
Why?
Antibodies, Antinuclear
1
1993
24
0.010
Why?
Risk Factors
1
2001
2345
0.010
Why?
Glycosylation
1
1993
64
0.010
Why?
Vero Cells
1
1993
50
0.010
Why?
Antigens, CD8
1
1993
29
0.010
Why?
Questionnaires
1
1998
1004
0.010
Why?
HIV Envelope Protein gp41
1
1993
4
0.010
Why?
Liver
1
1997
877
0.010
Why?
Binding, Competitive
1
1993
198
0.010
Why?
Random Allocation
1
1989
248
0.010
Why?
Retrospective Studies
1
1994
2267
0.010
Why?
Influenza A virus
1
1989
225
0.010
Why?
Histocytochemistry
1
1986
125
0.010
Why?
Molecular Weight
1
1986
353
0.010
Why?
Microscopy, Fluorescence
1
1986
264
0.010
Why?
Antibodies, Monoclonal
1
1986
711
0.010
Why?

Visualizations


Keefer's Networks

Concepts
_
Co-Authors
_
Similar People
_
Same Department